Aptamer-MiRNA Conjugates for Cancer Cell-Targeted Delivery

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression with significant roles in cancer initiation and progression.
• miRNAs show promise as therapeutic agents for cancer treatment.
• Clinical translation of miRNA therapeutics is hindered by challenges in achieving selective organ and tissue targeting.

Purpose of the Study:

• To explore aptamer-based strategies for the targeted delivery of microRNAs (miRNAs) to cancer cells.
• To address the critical need for safe and reliable delivery systems for miRNA cancer therapeutics.
• To discuss the direct conjugation of miRNAs to aptamers for selective cancer cell targeting.

Main Methods:

• Direct conjugation of microRNAs (miRNAs) to aptamers.
• Utilizing aptamers that target specific transmembrane receptors on cancer cells.
• Investigating the selective accumulation, intracellular uptake, and processing of miRNA-aptamer conjugates.

Main Results:

• Aptamer-based approaches offer efficient delivery tools for miRNA accumulation in target tumors.
• This method facilitates intracellular uptake and processing of miRNAs within cancer cells.
• The strategy enables functional gene silencing mediated by delivered miRNAs.

Conclusions:

• Direct conjugation of miRNAs to aptamers targeting transmembrane receptors is an innovative approach for selective cancer cell delivery.
• This method represents a significant step towards overcoming delivery hurdles in miRNA-based cancer therapy.
• Aptamer-conjugated miRNAs hold potential for effective cancer management through targeted gene silencing.